OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BMRN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioMarin Pharmaceutical (BMRN) Earnings Date & Reports

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BMRN is expected to report earnings to fall 39.93% to 86 cents per share on October 22

BioMarin Pharmaceutical BMRN Stock Earnings Reports

Q3'25

Est.

$0.87

Q2'25

Beat

by $0.61

Q1'25

Beat

by $0.43

Q4'24

Beat

by $0.37

Q3'24

Beat

by $0.38

The last earnings report on August 04 showed earnings per share of $1.44, beating the estimate of 82 cents. With 388.57K shares outstanding, the current market capitalization sits at 11.01B.

View a ticker or compare two or three

Compare

BMRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BMRN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMRN showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

770 Lindaro Street

Phone

+1 415 506-6700

Employees

3401

Web

https://www.biomarin.com